MedPath

ChapIce SPF 30 Lip Balm

Drug Facts

Approved
Approval ID

c7094485-a19f-41b7-88b8-d6d472adbff1

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 22, 2025

Manufacturers
FDA

OraLabs

DUNS: 801824756

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Avobenzone, Octisalate, Homosalate, Petrolatum

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63645-180
Application Number352
Product Classification
M
Marketing Category
C200263
G
Generic Name
Avobenzone, Octisalate, Homosalate, Petrolatum
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 22, 2025
FDA Product Classification

INGREDIENTS (7)

CERESINInactive
Quantity: 165 mg in 1 g
Code: Q1LS2UJO3A
Classification: IACT
ISOCETYL STEARATEInactive
Quantity: 23 mg in 1 g
Code: 3RJ7186O9W
Classification: IACT
AVOBENZONEActive
Quantity: 30 mg in 1 g
Code: G63QQF2NOX
Classification: ACTIB
.ALPHA.-TOCOPHEROL ACETATEInactive
Quantity: 5 mg in 1 g
Code: 9E8X80D2L0
Classification: IACT
OCTISALATEActive
Quantity: 50 mg in 1 g
Code: 4X49Y0596W
Classification: ACTIB
PETROLATUMActive
Quantity: 396 mg in 1 g
Code: 4T6H12BN9U
Classification: ACTIB
HOMOSALATEActive
Quantity: 80 mg in 1 g
Code: V06SV4M95S
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ChapIce SPF 30 Lip Balm - FDA Drug Approval Details